Articles
An updated coronary risk profile. A statement for health professionals
KM Anderson, PW Wilson, PM Odell, and WB Kannel
| You have reached the most complete version of this article accessible without further authentication.
More complete versions are available. Link to article |
Article topics:
- Biochemistry..Cholesterol
- Medicine..Epidemiology
- Religious Studies..Death
- Medicine..Mortality and Morbidity
- Medicine..Diabetes Epidemiology
- Medicine..High-Density Lipoproteins
- Medicine..Tobacco and Smoking
- Pharmacology..Heart Diseases (Drug Development)
- Sociology..Mortality
- Medicine..Epidemiology of Stroke
- Physiology..Blood Pressure
- Medicine..Etiology
This article has been cited by other articles:
 |
|
 |
|
  A. A.W.A. van der Heijden, M. M. Ortegon, L. W. Niessen, G. Nijpels, and J. M. Dekker Prediction of Coronary Heart Disease Risk in a General, Pre-Diabetic, and Diabetic Population During 10 Years of Follow-up: Accuracy of the Framingham, SCORE, and UKPDS Risk Functions: The Hoorn Study Diabetes Care, November 1, 2009; 32(11): 2094 - 2098. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Stollenwerk, A. Gerber, K. W. Lauterbach, and U. Siebert The German Coronary Artery Disease Risk Screening Model: Development, Validation, and Application of a Decision-Analytic Model for Coronary Artery Disease Prevention with Statins Med Decis Making, September 1, 2009; 29(5): 619 - 633. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Hadamitzky Reply J. Am. Coll. Cardiol. Img., July 1, 2009; 2(7): 915 - 915. [Full Text] [PDF]
|
|
|
|
 |
|
 E. Ketola, T. Laatikainen, and E. Vartiainen Evaluating risk for cardiovascular diseases--vain or value? How do different cardiovascular risk scores act in real life Eur J Public Health, May 29, 2009; (2009) ckp070v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Hadamitzky, B. Freissmuth, T. Meyer, F. Hein, A. Kastrati, S. Martinoff, A. Schomig, and J. Hausleiter Prognostic Value of Coronary Computed Tomographic Angiography for Prediction of Cardiac Events in Patients With Suspected Coronary Artery Disease J. Am. Coll. Cardiol. Img., April 1, 2009; 2(4): 404 - 411. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P.J. Halcox, A. E. Donald, E. Ellins, D. R. Witte, M. J. Shipley, E. J. Brunner, M. G. Marmot, and J. E. Deanfield Endothelial Function Predicts Progression of Carotid Intima-Media Thickness Circulation, February 24, 2009; 119(7): 1005 - 1012. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. de Ruijter, R. G J Westendorp, W. J J Assendelft, W. P J den Elzen, A. J M de Craen, S. le Cessie, and J. Gussekloo Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study BMJ, January 13, 2009; 338(jan08_2): a3083 - a3083. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Kjeldsen, T. A. Aksnes, R. H. Fagard, and G. Mancia CHAPTER 13 Hypertension ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C Power, K Atherton, and O Manor Co-occurrence of risk factors for cardiovascular disease by social class: 1958 British birth cohort J Epidemiol Community Health, December 1, 2008; 62(12): 1030 - 1035. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. King, C. Walker, G. Levy, C. Bottomley, P. Royston, S. Weich, J. A. Bellon-Saameno, B. Moreno, I. Svab, D. Rotar, et al. Development and Validation of an International Risk Prediction Algorithm for Episodes of Major Depression in General Practice Attendees: The PredictD Study Arch Gen Psychiatry, December 1, 2008; 65(12): 1368 - 1376. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A Al-Lawati, N. M Barakat, A. M Al-Lawati, and A. J Mohammed Optimal cut-points for body mass index, waist circumference and waist-to-hip ratio using the Framingham coronary heart disease risk score in an Arab population of the Middle East Diabetes and Vascular Disease Research, November 1, 2008; 5(4): 304 - 309. [Abstract] [PDF]
|
|
|
|
 |
|
 E. Gerdts, D. Cramariuc, G. de Simone, K. Wachtell, B. Dahlof, and R. B. Devereux Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the LIFE study) Eur J Echocardiogr, November 1, 2008; 9(6): 809 - 815. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C W Warren, N R Jones, J Chauvin, and A Peruga for the GTSS Collaborative Group Tobacco use and cessation counselling: cross-country. Data from the Global Health Professions Student Survey (GHPSS), 2005-7 Tob. Control, August 1, 2008; 17(4): 238 - 247. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Cirillo, M. P. Lanti, A. Menotti, M. Laurenzi, M. Mancini, A. Zanchetti, and N. G. De Santo Definition of Kidney Dysfunction as a Cardiovascular Risk Factor: Use of Urinary Albumin Excretion and Estimated Glomerular Filtration Rate Arch Intern Med, March 24, 2008; 168(6): 617 - 624. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E Vamvakopoulos, M. Kountouri, T. Marshall, and S. M Greenfield Lifestyle or Life-Saving Medicines? A Primary Healthcare Professional and Consumer Opinion Survey on Over-the-Counter Statins Ann. Pharmacother., March 1, 2008; 42(3): 413 - 420. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. B. D'Agostino Sr, R. S. Vasan, M. J. Pencina, P. A. Wolf, M. Cobain, J. M. Massaro, and W. B. Kannel General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study Circulation, February 12, 2008; 117(6): 743 - 753. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Berglund, M. Lefevre, H. N Ginsberg, P. M Kris-Etherton, P. J Elmer, P. W Stewart, A. Ershow, T. A Pearson, B. H Dennis, P. S Roheim, et al. Comparison of monounsaturated fat with carbohydrates as a replacement for saturated fat in subjects with a high metabolic risk profile: studies in the fasting and postprandial states Am. J. Clinical Nutrition, December 1, 2007; 86(6): 1611 - 1620. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. May, J. A C Sterne, M. Shipley, E. Brunner, R. d'Agostino, P. Whincup, Y. Ben-Shlomo, A. Carr, B. Ledergerber, J. D Lundgren, et al. A coronary heart disease risk model for predicting the effect of potent antiretroviral therapy in HIV-1 infected men Int. J. Epidemiol., December 1, 2007; 36(6): 1309 - 1318. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Authors/Task Force Members, I. Graham, D. Atar, K. Borch-Johnsen, G. Boysen, G. Burell, R. Cifkova, J. Dallongeville, G. De Backer, S. Ebrahim, et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts) Eur. Heart J., October 1, 2007; 28(19): 2375 - 2414. [Full Text] [PDF]
|
|
|
|
|
|
J. Macleod, C. Metcalfe, G. D. Smith, and C. Hart Does consideration of either psychological or material disadvantage improve coronary risk prediction? Prospective observational study of Scottish men J Epidemiol Community Health, September 1, 2007; 61(9): 833 - 837. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S Sampalis, S. Bissonnette, R. Habib, S. Boukas, and for the Ezetrol Add-On Investigators Reduction in Estimated Risk for Coronary Artery Disease After Use of Ezetimibe with a Statin Ann. Pharmacother., September 1, 2007; 41(9): 1345 - 1351. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Wachtell, P. M. Okin, M. H. Olsen, B. Dahlof, R. B. Devereux, H. Ibsen, S. E. Kjeldsen, L. H. Lindholm, M. S. Nieminen, and K. Thygesen Regression of Electrocardiographic Left Ventricular Hypertrophy During Antihypertensive Therapy and Reduction in Sudden Cardiac Death: The LIFE Study Circulation, August 14, 2007; 116(7): 700 - 705. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Schillaci, G. Parati, M. Pirro, G. Pucci, M. R. Mannarino, L. Sperandini, and E. Mannarino Ambulatory Arterial Stiffness Index Is Not a Specific Marker of Reduced Arterial Compliance Hypertension, May 1, 2007; 49(5): 986 - 991. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Revkin, C. L. Shear, H. G. Pouleur, S. W. Ryder, and D. G. Orloff Biomarkers in the Prevention and Treatment of Atherosclerosis: Need, Validation, and Future Pharmacol. Rev., March 1, 2007; 59(1): 40 - 53. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Gerdts, K. Wachtell, P. Omvik, J. E. Otterstad, L. Oikarinen, K. Boman, B. Dahlof, and R. B. Devereux Left Atrial Size and Risk of Major Cardiovascular Events During Antihypertensive Treatment: Losartan Intervention for Endpoint Reduction in Hypertension Trial Hypertension, February 1, 2007; 49(2): 311 - 316. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Wu, X. Liu, X. Li, Y. Li, L. Zhao, Z. Chen, Y. Li, X. Rao, B. Zhou, R. Detrano, et al. Estimation of 10-Year Risk of Fatal and Nonfatal Ischemic Cardiovascular Diseases in Chinese Adults Circulation, November 21, 2006; 114(21): 2217 - 2225. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Marshall Misleading Measurements: Modeling the Effects of Blood Pressure Misclassification in a United States Population Med Decis Making, November 1, 2006; 26(6): 624 - 632. [Abstract] [PDF]
|
|
|
|
 |
|
 T Marshall, S Bryan, P Gill, S Greenfield, K Gutridge, and Birmingham Patient Preferences Group Predictors of patients' preferences for treatments to prevent heart disease Heart, November 1, 2006; 92(11): 1651 - 1655. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Zgibor, G. A. Piatt, K. Ruppert, T. J. Orchard, and M. S. Roberts Deficiencies of Cardiovascular Risk Prediction Models for Type 1 Diabetes Diabetes Care, August 1, 2006; 29(8): 1860 - 1865. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Grotto, E. Grossman, M. Huerta, and Y. Sharabi Prevalence of Prehypertension and Associated Cardiovascular Risk Profiles Among Young Israeli Adults Hypertension, August 1, 2006; 48(2): 254 - 259. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. E. Goldman, D. R. Parker, C. B. Eaton, J. M. Borkan, R. Gramling, R. T. Cover, and D. K. Ahern Patients' Perceptions of Cholesterol, Cardiovascular Disease Risk, and Risk Communication Strategies Ann. Fam. Med, May 1, 2006; 4(3): 205 - 212. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kanbay, A. Yildirir, T. Ulus, M. Bilgi, A. Kucuk, and H. Muderrisoglu Rhesus Positivity and Low High-Density Lipoprotein Cholesterol: A New Link? Asian Cardiovasc Thorac Ann, April 1, 2006; 14(2): 119 - 122. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Laaser and J. Breckenkamp Trends in risk factor control in Germany 1984-1998: high blood pressure and total cholesterol Eur J Public Health, April 1, 2006; 16(2): 217 - 222. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. D. Rosen, M. F. Saad, S. Shea, K. Nasir, T. Edvardsen, G. Burke, M. Jerosch-Herold, D. K. Arnett, S. Lai, D. A. Bluemke, et al. Hypertension and Smoking Are Associated With Reduced Regional Left Ventricular Function in Asymptomatic Individuals: The Multi-Ethnic Study of Atherosclerosis J. Am. Coll. Cardiol., March 21, 2006; 47(6): 1150 - 1158. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G Manuel, J. Lim, P. Tanuseputro, G. M Anderson, D. A Alter, A. Laupacis, and C. A Mustard Revisiting Rose: strategies for reducing coronary heart disease. BMJ, March 18, 2006; 332(7542): 659 - 662. [Full Text] [PDF]
|
|
|
|
|
|
D. J. Jenkins, C. W. Kendall, D. A Faulkner, T. Nguyen, T. Kemp, A. Marchie, J. M. Wong, R. de Souza, A. Emam, E. Vidgen, et al. Assessment of the longer-term effects of a dietary portfolio of cholesterol-lowering foods in hypercholesterolemia Am. J. Clinical Nutrition, March 1, 2006; 83(3): 582 - 591. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Wannamethee, A. G. Shaper, L. Lennon, and R. W. Morris Metabolic Syndrome vs Framingham Risk Score for Prediction of Coronary Heart Disease, Stroke, and Type 2 Diabetes Mellitus Arch Intern Med, December 12, 2005; 165(22): 2644 - 2650. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Prepared by: British Cardiac Society, British Hype JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice Heart, December 1, 2005; 91(suppl_5): v1 - v52. [Full Text] [PDF]
|
|
|
|
|
|
E. Fossum, A. Moan, S. E. Kjeldsen, R. B. Devereux, S. Julius, S. M. Snapinn, J. M. Edelman, U. de Faire, F. Fyhrquist, H. Ibsen, et al. The Effect of Losartan Versus Atenolol on Cardiovascular Morbidity and Mortality in Patients With Hypertension Taking Aspirin: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study J. Am. Coll. Cardiol., September 6, 2005; 46(5): 770 - 775. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Franklin, K. Wachtell, V. Papademetriou, M. H. Olsen, R. B. Devereux, F. Fyhrquist, H. Ibsen, S. E. Kjeldsen, and B. Dahlof Cardiovascular Morbidity and Mortality in Hypertensive Patients With Lower Versus Higher Risk: A LIFE Substudy Hypertension, September 1, 2005; 46(3): 492 - 499. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Wachtell, B. Hornestam, M. Lehto, D. J. Slotwiner, E. Gerdts, M. H. Olsen, P. Aurup, B. Dahlof, H. Ibsen, S. Julius, et al. Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End point reduction in hypertension (LIFE) study J. Am. Coll. Cardiol., March 1, 2005; 45(5): 705 - 711. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Wachtell, M. Lehto, E. Gerdts, M. H. Olsen, B. Hornestam, B. Dahlof, H. Ibsen, S. Julius, S. E. Kjeldsen, L. H. Lindholm, et al. Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: The Losartan Intervention For End point reduction in hypertension (LIFE) study J. Am. Coll. Cardiol., March 1, 2005; 45(5): 712 - 719. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E C Jury and M R Ehrenstein Statins: immunomodulators for autoimmune rheumatic disease? Lupus, March 1, 2005; 14(3): 192 - 196. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Confalonieri, G. Garuti, M. S. Cattaruzza, J. F. Osborn, M. Antonelli, G. Conti, M. Kodric, O. Resta, S. Marchese, C. Gregoretti, et al. A chart of failure risk for noninvasive ventilation in patients with COPD exacerbation Eur. Respir. J., February 1, 2005; 25(2): 348 - 355. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Jenkins, C. W. Kendall, A. Marchie, D. A Faulkner, J. M. Wong, R. de Souza, A. Emam, T. L Parker, E. Vidgen, E. A Trautwein, et al. Direct comparison of a dietary portfolio of cholesterol-lowering foods with a statin in hypercholesterolemic participants Am. J. Clinical Nutrition, February 1, 2005; 81(2): 380 - 387. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Goehde, P. Hunold, F. M. Vogt, W. Ajaj, M. Goyen, C. U. Herborn, M. Forsting, J. F. Debatin, and S. G. Ruehm Full-Body Cardiovascular and Tumor MRI for Early Detection of Disease: Feasibility and Initial Experience in 298 Subjects Am. J. Roentgenol., February 1, 2005; 184(2): 598 - 611. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Okin, R. B. Devereux, S. Jern, S. E. Kjeldsen, S. Julius, M. S. Nieminen, S. Snapinn, K. E. Harris, P. Aurup, J. M. Edelman, et al. Regression of Electrocardiographic Left Ventricular Hypertrophy During Antihypertensive Treatment and the Prediction of Major Cardiovascular Events JAMA, November 17, 2004; 292(19): 2343 - 2349. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. J. Greenlund, J. B. Croft, and G. A. Mensah Prevalence of Heart Disease and Stroke Risk Factors in Persons With Prehypertension in the United States, 1999-2000 Arch Intern Med, October 25, 2004; 164(19): 2113 - 2118. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. von Birgelen, M. Hartmann, G. S. Mintz, K. G. van Houwelingen, N. Deppermann, A. Schmermund, D. Bose, H. Eggebrecht, T. Neumann, M. Gossl, et al. Relationship Between Cardiovascular Risk as Predicted by Established Risk Scores Versus Plaque Progression as Measured by Serial Intravascular Ultrasound in Left Main Coronary Arteries Circulation, September 21, 2004; 110(12): 1579 - 1585. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Wachtell, M. H. Olsen, and H. Ibsen Albuminuria and Mortality in Hypertension Ann Intern Med, August 3, 2004; 141(3): 245 - 245. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Bessant, A. Hingorani, L. Patel, A. MacGregor, D. A. Isenberg, and A. Rahman Risk of coronary heart disease and stroke in a large British cohort of patients with systemic lupus erythematosus Rheumatology, July 1, 2004; 43(7): 924 - 929. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. E. Schuit, H.-H. S. Oei, J. C. M. Witteman, C. H. Geurts van Kessel, J. B. J. van Meurs, R. L. Nijhuis, J. P. T. M. van Leeuwen, F. H. de Jong, M. C. Zillikens, A. Hofman, et al. Estrogen Receptor {alpha} Gene Polymorphisms and Risk of Myocardial Infarction JAMA, June 23, 2004; 291(24): 2969 - 2977. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Franco, S. Oparil, and O. A. Carretero Hypertensive Therapy: Part I Circulation, June 22, 2004; 109(24): 2953 - 2958. [Full Text] [PDF]
|
|
|
|
|
|
J.-P Empana Screening for cardiovascular disease: reply Eur. Heart J., June 1, 2004; 25(11): 996 - 997. [Full Text] [PDF]
|
|
|
|
|
|
S. C. Smith Jr, R. V. Milani, D. K. Arnett, J. R. Crouse III, M. M. McDermott, P. M Ridker, R. S. Rosenson, K. A. Taubert, and P. W.F. Wilson Atherosclerotic Vascular Disease Conference: Writing Group II: Risk Factors Circulation, June 1, 2004; 109(21): 2613 - 2616. [Full Text] [PDF]
|
|
|
|
|
|
L. Oikarinen, M. S. Nieminen, M. Viitasalo, L. Toivonen, S. Jern, B. Dahlof, R. B. Devereux, P. M. Okin, and for the LIFE Study Investigators QRS Duration and QT Interval Predict Mortality in Hypertensive Patients With Left Ventricular Hypertrophy: The Losartan Intervention for Endpoint Reduction in Hypertension Study Hypertension, May 1, 2004; 43(5): 1029 - 1034. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Marshall When measurements are misleading: modelling the effects of blood pressure misclassification in the English population BMJ, April 17, 2004; 328(7445): 933 - 933. [Full Text] [PDF]
|
|
|
|
|
|
S. Ebrahim, D. Montaner, and D. A Lawlor Clustering of risk factors and social class in childhood and adulthood in British women's heart and health study: cross sectional analysis BMJ, April 10, 2004; 328(7444): 861. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-W. Hense Observations, predictions and decisions--assessing cardiovascular risk assessment Int. J. Epidemiol., April 1, 2004; 33(2): 235 - 239. [Full Text] [PDF]
|
|
|
|
 |
|
 K. Armstrong, J. S. Schwartz, T. Randall, S. C. Rubin, and B. Weber Hormone Replacement Therapy and Life Expectancy After Prophylactic Oophorectomy in Women With BRCA1/2 Mutations: A Decision Analysis J. Clin. Oncol., March 15, 2004; 22(6): 1045 - 1054. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-J. Janket, M. Qvarnstrom, J. H. Meurman, A. E. Baird, P. Nuutinen, and J. A. Jones Asymptotic Dental Score and Prevalent Coronary Heart Disease Circulation, March 9, 2004; 109(9): 1095 - 1100. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Emberson, P. Whincup, R. Morris, M. Walker, and S. Ebrahim Evaluating the impact of population and high-risk strategies for the primary prevention of cardiovascular disease Eur. Heart J., March 2, 2004; 25(6): 484 - 491. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Greenland, L. LaBree, S. P. Azen, T. M. Doherty, and R. C. Detrano Coronary Artery Calcium Score Combined With Framingham Score for Risk Prediction in Asymptomatic Individuals JAMA, January 14, 2004; 291(2): 210 - 215. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Wachtell, H. Ibsen, M. H. Olsen, K. Borch-Johnsen, L. H. Lindholm, C. E. Mogensen, B. Dahlof, R. B. Devereux, G. Beevers, U. de Faire, et al. Albuminuria and Cardiovascular Risk in Hypertensive Patients with Left Ventricular Hypertrophy: The LIFE Study Ann Intern Med, December 2, 2003; 139(11): 901 - 906. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. V. Chobanian, G. L. Bakris, H. R. Black, W. C. Cushman, L. A. Green, J. L. Izzo Jr, D. W. Jones, B. J. Materson, S. Oparil, J. T. Wright Jr, et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Hypertension, December 1, 2003; 42(6): 1206 - 1252. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-W. Hense Risk factor scoring for coronary heart disease BMJ, November 29, 2003; 327(7426): 1238 - 1239. [Full Text] [PDF]
|
|
|
|
|
|
T. Marshall Coronary heart disease prevention: insights from modelling incremental cost effectiveness BMJ, November 29, 2003; 327(7426): 1264. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Brindle, J. Emberson, F. Lampe, M. Walker, P. Whincup, T. Fahey, and S. Ebrahim Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study BMJ, November 29, 2003; 327(7426): 1267. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.P Empana, P Ducimetiere, D Arveiler, J Ferrieres, A Evans, J.B Ruidavets, B Haas, J Yarnell, A Bingham, P Amouyel, et al. Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations?: The PRIME Study Eur. Heart J., November 1, 2003; 24(21): 1903 - 1911. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Sarnak, A. S. Levey, A. C. Schoolwerth, J. Coresh, B. Culleton, L. L. Hamm, P. A. McCullough, B. L. Kasiske, E. Kelepouris, M. J. Klag, et al. Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A Statement From the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention Hypertension, November 1, 2003; 42(5): 1050 - 1065. [Full Text] [PDF]
|
|
|
|
|
|
M. J. Sarnak, A. S. Levey, A. C. Schoolwerth, J. Coresh, B. Culleton, L. L. Hamm, P. A. McCullough, B. L. Kasiske, E. Kelepouris, M. J. Klag, et al. Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A Statement From the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention Circulation, October 28, 2003; 108(17): 2154 - 2169. [Full Text] [PDF]
|
|
|
|
|
|
M. Gulati, D. K. Pandey, M. F. Arnsdorf, D. S. Lauderdale, R. A. Thisted, R. H. Wicklund, A. J. Al-Hani, and H. R. Black Exercise Capacity and the Risk of Death in Women: The St James Women Take Heart Project Circulation, September 30, 2003; 108(13): 1554 - 1559. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Jenkins, C. W. Kendall, A. Marchie, A. L Jenkins, L. S. Augustin, D. S Ludwig, N. D Barnard, and J. W Anderson Type 2 diabetes and the vegetarian diet Am. J. Clinical Nutrition, September 1, 2003; 78(3): 610S - 616. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Oren, L. E. Vos, C. S. P. M. Uiterwaal, D. E. Grobbee, and M. L. Bots Cardiovascular Risk Factors and Increased Carotid Intima-Media Thickness in Healthy Young Adults: The Atherosclerosis Risk in Young Adults (ARYA) Study Arch Intern Med, August 11, 2003; 163(15): 1787 - 1792. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. B. Devereux, B. Dahlof, S. E. Kjeldsen, S. Julius, P. Aurup, G. Beevers, J. M. Edelman, U. de Faire, F. Fyhrquist, Sigrid Helle Berg, et al. Effects of Losartan or Atenolol in Hypertensive Patients without Clinically Evident Vascular Disease: A Substudy of the LIFE Randomized Trial Ann Intern Med, August 5, 2003; 139(3): 169 - 177. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. A. Jenkins, C. W. C. Kendall, A. Marchie, D. A. Faulkner, J. M. W. Wong, R. de Souza, A. Emam, T. L. Parker, E. Vidgen, K. G. Lapsley, et al. Effects of a Dietary Portfolio of Cholesterol-Lowering Foods vs Lovastatin on Serum Lipids and C-Reactive Protein JAMA, July 23, 2003; 290(4): 502 - 510. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Asia Pacific Cohort Studies Collaboration Blood Pressure Indices and Cardiovascular Disease in the Asia Pacific Region: A Pooled Analysis Hypertension, July 1, 2003; 42(1): 69 - 75. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Wilson, A Johnston, J Robson, N Poulter, D Collier, G Feder, and M J Caulfield Comparison of methods to identify individuals at increased risk of coronary disease from the general population BMJ, June 25, 2003; 326(7404): 1436. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. M. van der Meer, M. P. M. de Maat, A. J. Kiliaan, D. A. M. van der Kuip, A. Hofman, and J. C. M. Witteman The Value of C-Reactive Protein in Cardiovascular Risk Prediction: The Rotterdam Study Arch Intern Med, June 9, 2003; 163(11): 1323 - 1328. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.M. Conroy, K. Pyorala, A.P. Fitzgerald, S. Sans, A. Menotti, G. De Backer, D. De Bacquer, P. Ducimetiere, P. Jousilahti, U. Keil, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project Eur. Heart J., June 1, 2003; 24(11): 987 - 1003. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Sabate, E. Haddad, J. S Tanzman, P. Jambazian, and S. Rajaram Serum lipid response to the graduated enrichment of a Step I diet with almonds: a randomized feeding trial Am. J. Clinical Nutrition, June 1, 2003; 77(6): 1379 - 1384. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-W. Hense, H. Schulte, H. Lowel, G. Assmann, and U. Keil Framingham risk function overestimates risk of coronary heart disease in men and women from Germany--results from the MONICA Augsburg and the PROCAM cohorts Eur. Heart J., May 2, 2003; 24(10): 937 - 945. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Skogsberg, K. Kannisto, T. N. Cassel, A. Hamsten, P. Eriksson, and E. Ehrenborg Evidence That Peroxisome Proliferator-Activated Receptor Delta Influences Cholesterol Metabolism in Men Arterioscler Thromb Vasc Biol, April 1, 2003; 23(4): 637 - 643. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. McNulty, E. Ur, and G. Williams A Randomized Trial of Sibutramine in the Management of Obese Type 2 Diabetic Patients Treated With Metformin Diabetes Care, January 1, 2003; 26(1): 125 - 131. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Voss, P. Cullen, H. Schulte, and G. Assmann Prediction of risk of coronary events in middle-aged men in the Prospective Cardiovascular Munster Study (PROCAM) using neural networks Int. J. Epidemiol., December 1, 2002; 31(6): 1253 - 1262. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Committee Members, R. J. Gibbons, G. J. Balady, J. Timothy Bricker, B. R. Chaitman, G. F. Fletcher, V. F. Froelicher, D. B. Mark, B. D. McCallister, A. N. Mooss, et al. ACC/AHA 2002 guideline update for exercise testing: summary article: A report of the American college of cardiology/American heart association task force on practice guidelines (committee to update the 1997 exercise testing guidelines) J. Am. Coll. Cardiol., October 16, 2002; 40(8): 1531 - 1540. [Full Text] [PDF]
|
|
|
|
|
|
P Tyden, O Hansen, G Engstrom, B Hedblad, and L Janzon Myocardial infarction in an urban population: worse long term prognosis for patients from less affluent residential areas J Epidemiol Community Health, October 1, 2002; 56(10): 785 - 790. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Gibbons, G. J. Balady, J. Timothy Bricker, B. R. Chaitman, G. F. Fletcher, V. F. Froelicher, D. B. Mark, B. D. McCallister, A. N. Mooss, M. G. O'Reilly, et al. ACC/AHA 2002 Guideline Update for Exercise Testing: Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines) Circulation, October 1, 2002; 106(14): 1883 - 1892. [Full Text] [PDF]
|
|
|
|
|
|
S. E. Kjeldsen, B. Dahlof, R. B. Devereux, S. Julius, P. Aurup, J. Edelman, G. Beevers, U. de Faire, F. Fyhrquist, H. Ibsen, et al. Effects of Losartan on Cardiovascular Morbidity and Mortality in Patients With Isolated Systolic Hypertension and Left Ventricular Hypertrophy: A Losartan Intervention For Endpoint Reduction (LIFE) Substudy JAMA, September 25, 2002; 288(12): 1491 - 1498. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J.A. Jenkins, C. W.C. Kendall, A. Marchie, T. L. Parker, P. W. Connelly, W. Qian, J. S. Haight, D. Faulkner, E. Vidgen, K. G. Lapsley, et al. Dose Response of Almonds on Coronary Heart Disease Risk Factors: Blood Lipids, Oxidized Low-Density Lipoproteins, Lipoprotein(a), Homocysteine, and Pulmonary Nitric Oxide: A Randomized, Controlled, Crossover Trial Circulation, September 10, 2002; 106(11): 1327 - 1332. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Schomig, J. Mehilli, H. Holle, K. Hosl, D. Kastrati, J.u. Pache, M. Seyfarth, F.-J. Neumann, J. Dirschinger, and A. Kastrati Statin treatment following coronary artery stenting and one-year survival J. Am. Coll. Cardiol., September 4, 2002; 40(5): 854 - 861. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. A. Jenkins, C. W. C. Kendall, L. S. A. Augustin, M. C. Martini, M. Axelsen, D. Faulkner, E. Vidgen, T. Parker, H. Lau, P. W. Connelly, et al. Effect of Wheat Bran on Glycemic Control and Risk Factors for Cardiovascular Disease in Type 2 Diabetes Diabetes Care, September 1, 2002; 25(9): 1522 - 1528. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Prediction of mortality from coronary heart disease among diverse populations: is there a common predictive function? Heart, September 1, 2002; 88(3): 222 - 228. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Jenkins, C. W. Kendall, C.-J. C Jackson, P. W Connelly, T. Parker, D. Faulkner, E. Vidgen, S. C Cunnane, L. A Leiter, and R. G Josse Effects of high- and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women Am. J. Clinical Nutrition, August 1, 2002; 76(2): 365 - 372. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||